• PROGENICS PHARMACEUTICALS IN Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2007 FY2006 FY2005 FY2004 FY2003
    Assets
    Cash and Short Term Investments 130.42 M 125.79 M 166.06 M 30.22 M 59.12 M
    Net Receivables 2.00 M 1.70 M 3.29 M 1.30 M 797,000.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 3.11 M 3.18 M 2.56 M 1.81 M 1.46 M
    Current Assets Total 135.53 M 130.67 M 171.90 M 33.33 M 61.38 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 371,000.00 0.00 541,000.00
    Other Investments 40.50 M 23.86 M 7.04 M 986,000.00 6.54 M
    Property, Plant & Equipment Net 13.51 M 11.39 M 4.16 M 4.69 M 3.89 M
    Property, Plant & Equipment Gross 25.68 M 20.62 M 11.96 M 11.03 M 8.91 M
    Accumulated Depreciation 12.17 M 9.23 M 7.81 M 6.34 M 5.02 M
    Other Assets 0.00 0.00 538,000.00 535,000.00 532,000.00
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 538,000.00 535,000.00 532,000.00 131,000.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 189.54 M 165.91 M 184.00 M 39.54 M 72.89 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 1.49 M 990,000.00 1.14 M 734,000.00 701,000.00
    Income Taxes Payable 0.00 0.00 201,000.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 29.90 M 36.29 M 32.58 M 5.49 M 3.15 M
    Current Liabilities Total 32.55 M 38.84 M 34.80 M 7.66 M 5.15 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 9.13 M 16.10 M 36.42 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 359,000.00 123,000.00 49,000.00 42,000.00 50,000.00
    Total Liabilities 42.04 M 55.06 M 71.27 M 7.71 M 5.20 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 147.50 M 110.85 M 112.73 M 31.84 M 67.68 M
    Common Stock 39,000.00 34,000.00 33,000.00 22,000.00 22,000.00
    Capital Surplus 401.50 M 321.32 M 306.08 M 153.47 M 144.94 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 6,000.00 -145,000.00 -4.50 M -2.25 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00
    Retained Earnings -254.05 M -210.36 M -188.74 M -119.31 M -77.29 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities -148,000.00 -91,000.00 14,000.00 106,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 189.54 M 165.91 M 184.00 M 39.54 M 72.89 M
    Common Shares Outstanding 29.75 M 26.20 M 25.23 M 17.28 M 16.64 M